Advertisement

Topics

Hexal Australia Company Profile

01:26 EDT 19th September 2018 | BioPortfolio

Hexal Australia was formed as a joint venture with Hexal AG, Germany in 1995 under the leadership of Clemens von Oswald. After an intensive preparation period prior to launching the company, two products were released onto the market in August 1997.Currently Hexal Australia has a product base of 45 active substances and 118 product lines. Hexal Australia plans to substantially expand the range further.
Hexal Australia is now recognised as a major force within the Australian generic medicines (lower cost brands) market segment.

Location

Level 4, Suite 1-6, 100 Harris Street
Pyrmont
New South Wales
NSW 2009
Australia

Contact

Phone: 61 2 9566 1500
Fax: 61 2 9566 1458


News Articles [255 Associated News Articles listed on BioPortfolio]

Human medicines European public assessment report (EPAR): Filgrastim Hexal, filgrastim, Revision: 14, Authorised

Human medicines European public assessment report (EPAR): Filgrastim Hexal, filgrastim, Revision: 13, Authorised

Human medicines European public assessment report (EPAR): Temozolomide Hexal, temozolomide, Revision: 14, Authorised

Pending EC decision: Epoetin Alfa Hexal, epoetin alfa, Opinion date: 26-Jul-2018

OneTrust Expands in Australia and New Zealand with New Melbourne Office and Integrated ANZ ...

MELBOURNE, Australia, Aug. 19, 2018 /PRNewswire/ -- OneTrust, the global leader in privacy management and marketing compliance today announced its expansion in Australia and New Read more...

Swiss Clinic Slams Australia Over Scientist, 104, Who Wants to Die (Update)

(Medical Xpress) – A member of a Swiss clinic set to help Australia’s oldest scientist end his life has said it is an “atrocity” that Australia had not allowed the 104-year-old...

Valeritas launches V-Go Insulin delivery device in Australia

Valeritas CEO, John Timberlake said: “We are pleased to announce V-Go Wearable Insulin Delivery device is now available for patients with type 2 diabetes in Australia. Australia is The post Valerit...

Vertex's Orkambi CF drug okayed for funding in Australia

Vertex’s Orkambi (lumacaftor+ivacaftor) cystic fibrosis drug is to be reimbursed in Australia’s publicly funded health system after it was cleared by a cost-effectiveness committee. The decision ...

Clinical Trials [157 Associated Clinical Trials listed on BioPortfolio]

Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients

This is a randomized, controlled, double-blind, multicenter multinational safety study involving about 300 predialysis patients aged 18 years or above suffering from anemia. Symptomatic a...

Non-interventional, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Stem Cell Donors

Data collection on the safety and efficacy of Zarzio® / Filgrastim HEXAL® in adult healthy unrelated stem cell donors undergoing peripheral blood progenitor cell mobilization.

Western Australian Pre-exposure Prophylaxis for HIV Implementation Trial

Despite all prevention efforts, many people in Australia continue to be infected with HIV. The Seventh National HIV Strategy 2014-2017 in Australia aims to work towards the elimination of ...

Patient Retention in HIV Medical Care in a Primary Care Practice in Australia

The purpose of this study is to determine linkage and retention in care in patients with HIV infection and reasons for loss to follow up Care in a High HIV-caseload Inner City Primary Care...

LBH589 Alone or in Combination With Erythropoietin Stimulating Agents (ESA) in Patients With Low or Int-1 Risk MDS

This study will assess the efficacy and safety of LBH589 as single agent and in combination with ESA in red blood cell transfusion-dependent Low and Int-1 MDS patients being either refract...

Companies [446 Associated Companies listed on BioPortfolio]

Hexal Australia

Hexal Australia was formed as a joint venture with Hexal AG, Germany in 1995 under the leadership of Clemens von Oswald. After an intensive preparation period prior to launching the company, two produ...

Food Science Australia

Food Science Australia is Australia's largest and most diversified food research organisation and a joint venture of CSIRO and the Victorian Government. We are committed to turning scientific researc...

Australia-New Zealand Biotech Alliance

A Memorandum of Understanding between the Governments of New South Wales, Queensland, South Australia, Tasmania, Victoria, Western Australia, the Australian Capital Territory, the Northern Territory a...

Novotech (Australia) Pty Ltd

Novotech is the largest independent CRO in Australia. With operations in the US, Novotech is uniquely positioned to offer clinical research services on the ground in both the US and Australia/New Zea...

George Weber & Associates

George Weber & Associates is a well established, successful healthcare marketing practice based in Sydney, Australia. Its client base includes companies from the U.S. Australia, Hong Kong and Singapor...

More Information about "Hexal Australia" on BioPortfolio

We have published hundreds of Hexal Australia news stories on BioPortfolio along with dozens of Hexal Australia Clinical Trials and PubMed Articles about Hexal Australia for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hexal Australia Companies in our database. You can also find out about relevant Hexal Australia Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...


Corporate Database Quicklinks



Searches Linking to this Company Record